Users Discontinuing Slimming Injections Regain Pounds Four Times Faster Than Dieters

Fresh analysis suggests that individuals who discontinue popular weight-loss injections like Mounjaro or Wegovy tend to recover shed pounds at a significantly accelerated pace than those who halt traditional diet and exercise plans.

Published data in a prominent medical journal demonstrates that while overweight people frequently drop about a fifth of their body weight while undergoing treatment, the weight returns at an average rate of nearly a kilo each month upon discontinuation.

"Users purchasing such medications must be informed of the risk of fast weight regain when the medication ends," warns researcher Dr. Susan Jebb.

This pace of regain suggests a return to pre-treatment mass in about one and a half years.

Analyzing Approaches

The analysis, which examined 37 of trials involving thousands of patients, compared the effects of GLP-1 agonists with other pills.

Scientists point out that individuals who shed pounds through dieting typically experience a less rapid weight regain—approximately 100 grams monthly—after stopping.

Understanding the Fast Rebound

Experts suggest the mode of action of the injections accounts for the heightened regain.

The injections mimic a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.

"Artificially providing GLP-1 concentrations several times higher than normal could lead to the system to produce less of its own natural hormone, and may also diminish responsiveness to its actions," said Dr. Adam Collins, a nutrition researcher.

"Withdrawal of this GLP-1 'fix' means appetite is no longer kept in check, making binge eating far more likely."

A Lifelong Condition?

Health authorities advise the injections for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.

A number of clinicians argue that, due to the significant potential of weight regain, the therapy should be considered long-term.

This perspective is reinforced by drug manufacturers, who state that the results "underscore the long-term character of excess weight," akin to managing conditions like diabetes.

Patient Testimonies

People who have come off the jabs report a powerful return of cravings.

"I experienced a switch that goes on and I was suddenly ravenous," recalled an individual.

This difficulty is compounded if individuals have not developed permanent lifestyle or habit modifications during therapy.

Growing Use

Figures show that millions of people in the UK have used these injections in the past year, with demand continuing to grow.

• Use is greater among women than men.
• The middle-aged demographic shows the greatest usage rates.
• A large proportion access the medications through private healthcare rather than the NHS.

Finally, researchers emphasize that while the jabs are potent agents for shedding pounds, they are not a permanent fix and long-term success relies on ongoing behavioural changes.